Xstim, Inc. Receives FDA Approval for Xstim™ Spine Fusion Stimulator
Xstim, Inc. Receives FDA Approval for Xstim™ Spine Fusion Stimulator. (prnewswire.com)
Continue Reading
Xstim, Inc. Receives FDA Approval for Xstim™ Spine Fusion Stimulator
source: shutterstock.com
Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy
For decades researchers have had to isolate segments of genes in order to study them. They called the isolated gene a “mini gene.” Ravindra Singh, a biomedical science professor at…
Continue Reading
Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy
source: pixabay.com
Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
Duchenne muscular dystrophy (DMD) is an inherited disease that weakens a child’s muscles and eventually spreads throughout the child’s body. DMD is caused by mutations in the gene that helps…
Continue Reading
Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
source: shutterstock.com
First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
According to a press release from the US Food and Drug Administration (FDA), the agency has approved the medication resmetirom (marketed as Rezdiffra) as the first-ever treatment intended to treat…
Continue Reading
First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
